Clinical Trials: Phase I-II Study of Dasatinib and Erlotinib in Non-Small Cell Lung Cancer

Sponsor and Collaborators
M.D. Anderson Cancer Center
Bristol-Myers Squibb
OSI Pharmaceuticals

Contact
Faye M. Johnson, MD, PhD
713-792-6363

Principal Investigator
Faye M. Johnson, MD, PhD
University of Texas MD Anderson Cancer Center

ClinicalTrials.gov Identifier 
NCT00826449

Loading links....
You must be a registered member of ONA to post a comment.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs